CAV-1 in Jak/STAT Signaling, Lactation, & Breast Cancer

Jak/STAT 信号传导、哺乳期中的 CAV-1

基本信息

  • 批准号:
    6569872
  • 负责人:
  • 金额:
    $ 37.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-01-23 至 2007-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term objective of this proposal is to understand the role of caveolin-1 in i) Jak/STAT signaling, ii) lactation, and iii) the pathogenesis of breast cancer. Caveolae function as "message centers" for regulating signal transduction. Caveolin-1 (Cav-1) is the principal structural protein of caveolae membranes that are found in most cells. We mapped human CAV-1 to a suspected tumor suppressor locus (7q31.1/D7S522). In addition, the Cav-1 gene is mutated (P132L) in up to 16% of human breast cancers. The aim of this proposal is to test the hypothesis that Cav-1 expression is important for regulating lactation via modulation of Jak/STAT signaling and that loss of Cav-1 contributes to the oncogenicity of breast cancer cells. To test this hypothesis, we will use a variety of complementary in vivo approaches, such as i) a Cav-1 null mouse model and ii) the development of transgenic mice that express dominant-negative Cav-1 (PI32L) found in human breast cancers. The three Specific Aims of the project are: 1) To determine the role of Cav-1 in negatively regulating Jak/STAT signaling. We will examine the effects of Cav-1 on the activation of Jak/STAT signaling in cultured mammary epithelial cells that are responsive to prolactin. Our preliminary results indicate that Cav-1 negatively regulates Jak/STAT5a signaling by inhibiting Jak-mediated phosphorylation of STAT5a; 2) To examine the role of Cav-1 in lactation and epithelial cell hyperplasia. Signaling from the hormone prolactin vial the Jak/STAT pathway controls normal mammary gland development. Thus, if Cav-1 were a negative regulator of Jak/STAT signaling, we would predict that a loss of Cav-1 expression leads to premature lactation. Indeed, our preliminary results show that Cav-1 null mice exhibit premature lactation, as well as hyper-activation of the Jak/STAT5a signaling cascade; and 3) To determine if transgenic expression of Cav-1 (P132L) predisposes towards mammary tumor development. For this purpose, we will generate Cav-1 (P132L) mice that transgenically express this form of Cav-1 in the mammary gland. Our preliminary results indicate that Cav-1 (P132L) acts in a dominant-negative fashion in cultured cells. In addition, our preliminary results with Cav-1 null mice show early development of wide-spread mammary epithelial hyperplasia. We predict that this phenotype will be accelerated Cav-1 (P132L) transgenic mice. We will cross Cav-1 (P132L) transgenic mice with other well-established models of mammary tumorigenesis, such as MMTVErbB2 and MMTV-polyoma middle T mice. It is expected that these studies will contribute fundamental knowledge towards understanding the role of Cav-1 in Jak/STAT signaling and mammary tumorigenesis in vivo.
描述(由申请人提供):本提案的长期目标是了解小窝蛋白-1在i)Jak/STAT信号传导,ii)哺乳和iii)乳腺癌发病机制中的作用。小窝作为调节信号转导的“信息中心”。小窝蛋白-1(Caveolin-1,Cav-1)是存在于大多数细胞中的小窝膜的主要结构蛋白。我们将人CAV-1定位到一个疑似肿瘤抑制基因座(7q31.1/D 7S 522)。此外,Cav-1基因在高达16%的人类乳腺癌中发生突变(P132 L)。该提案的目的是检验Cav-1表达对通过调节Jak/STAT信号传导调节泌乳很重要以及Cav-1的缺失有助于乳腺癌细胞的致癌性的假设。为了检验这一假设,我们将使用各种互补的体内方法,例如i)Cav-1无效小鼠模型和ii)表达在人乳腺癌中发现的显性阴性Cav-1(PI 32 L)的转基因小鼠的开发。本项目的三个具体目的是:1)确定Cav-1在负调控Jak/STAT信号转导中的作用。我们将研究Cav-1对催乳素敏感的培养乳腺上皮细胞中Jak/STAT信号转导激活的影响。我们的初步研究结果表明Cav-1通过抑制Jak介导的STAT 5a磷酸化来负性调节Jak/STAT 5a信号传导; 2)研究Cav-1在哺乳和上皮细胞增生中的作用。来自催乳素小瓶的激素信号传导Jak/STAT途径控制正常乳腺发育。因此,如果Cav-1是Jak/STAT信号传导的负调节因子,我们可以预测Cav-1表达的丧失会导致过早泌乳。实际上,我们的初步结果显示Cav-1缺失小鼠表现出过早泌乳,以及Jak/STAT 5a信号级联的过度激活;和3)确定Cav-1(P132 L)的转基因表达是否倾向于乳腺肿瘤的发展。为此,我们将产生Cav-1(P132 L)小鼠,转基因表达这种形式的Cav-1在乳腺。我们的初步结果表明,Cav-1(P132 L)在培养细胞中以显性负性方式起作用。此外,我们对Cav-1基因敲除小鼠的初步研究结果显示,早期出现广泛的乳腺上皮增生。我们预测这种表型将加速Cav-1(P132 L)转基因小鼠的产生。我们将Cav-1(P132 L)转基因小鼠与其他成熟的乳腺肿瘤发生模型,如MMTVErbB 2和MMTV-polyoma middle T小鼠杂交。预计这些研究将有助于了解Cav-1在体内Jak/STAT信号传导和乳腺肿瘤发生中的作用的基础知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL P LISANTI其他文献

MICHAEL P LISANTI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL P LISANTI', 18)}}的其他基金

CAV-1 Epithelial-Stromal Interactions and Breast Cancer
CAV-1 上皮-间质相互作用与乳腺癌
  • 批准号:
    7261643
  • 财政年份:
    2007
  • 资助金额:
    $ 37.16万
  • 项目类别:
CAV-1 Epithelial-Stromal Interactions and Breast Cancer
CAV-1 上皮-间质相互作用与乳腺癌
  • 批准号:
    8105212
  • 财政年份:
    2007
  • 资助金额:
    $ 37.16万
  • 项目类别:
CAV-1 Epithelial-Stromal Interactions and Breast Cancer
CAV-1 上皮-间质相互作用与乳腺癌
  • 批准号:
    7479092
  • 财政年份:
    2007
  • 资助金额:
    $ 37.16万
  • 项目类别:
CAV-1 Epithelial-Stromal Interactions and Breast Cancer
CAV-1 上皮-间质相互作用与乳腺癌
  • 批准号:
    7667735
  • 财政年份:
    2007
  • 资助金额:
    $ 37.16万
  • 项目类别:
CAV-1 Epithelial-Stromal Interactions and Breast Cancer
CAV-1 上皮-间质相互作用与乳腺癌
  • 批准号:
    7880060
  • 财政年份:
    2007
  • 资助金额:
    $ 37.16万
  • 项目类别:
CAV-1 in Jak/STAT Signaling, Lactation, & Breast Cancer
Jak/STAT 信号传导、哺乳期中的 CAV-1
  • 批准号:
    7161739
  • 财政年份:
    2003
  • 资助金额:
    $ 37.16万
  • 项目类别:
CAV-1 in Jak/STAT Signaling, Lactation, & Breast Cancer
Jak/STAT 信号传导、哺乳期中的 CAV-1
  • 批准号:
    7290102
  • 财政年份:
    2003
  • 资助金额:
    $ 37.16万
  • 项目类别:
CAV-1, Stat5a Signaling, and Estrogen-Dependent Breast Cancer
CAV-1、Stat5a 信号传导和雌激素依赖性乳腺癌
  • 批准号:
    7743796
  • 财政年份:
    2003
  • 资助金额:
    $ 37.16万
  • 项目类别:
CAV-1 in Jak/STAT Signaling, Lactation, & Breast Cancer
Jak/STAT 信号传导、哺乳期中的 CAV-1
  • 批准号:
    7001321
  • 财政年份:
    2003
  • 资助金额:
    $ 37.16万
  • 项目类别:
CAV-1, Stat5a Signaling, and Estrogen-Dependent Breast Cancer
CAV-1、Stat5a 信号传导和雌激素依赖性乳腺癌
  • 批准号:
    7559728
  • 财政年份:
    2003
  • 资助金额:
    $ 37.16万
  • 项目类别:

相似海外基金

ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    6238317
  • 财政年份:
    1997
  • 资助金额:
    $ 37.16万
  • 项目类别:
CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
生物信号转导中的细胞粘附
  • 批准号:
    3732412
  • 财政年份:
  • 资助金额:
    $ 37.16万
  • 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    5210031
  • 财政年份:
  • 资助金额:
    $ 37.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了